Skip to main content
TRDA
NASDAQ Life Sciences

Entrada's DMD Drug Advances to Higher Dose Cohort 2 in Phase 1/2 Study After Safety Review

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$7.056
Mkt Cap
$268.25M
52W Low
$4.93
52W High
$16.45
52W Position info
43% above low
Off High info
57% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

TRDA sits 43% above its 52-week low of $4.93.

Summary

An independent Data Monitoring Committee (DMC) recommended Entrada Therapeutics proceed to Cohort 2 of its ELEVATE-45-201 study for ENTR-601-45, increasing the dose to 10 mg/kg from 5 mg/kg. This positive development indicates favorable safety data for the Duchenne muscular dystrophy (DMD) candidate. This news provides a positive clinical update for a key pipeline asset, following a significant stock decline in early May related to detailed data from a different DMD study. The dose escalation recommendation from an independent committee is a strong positive signal for the drug's safety and potential efficacy. The company expects to report Cohort 1 data for ELEVATE-45-201 in mid-2026.

At the time of this announcement, TRDA was trading at $7.06 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $268.3M. The 52-week trading range was $4.93 to $16.45. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

TRDA - Latest Insights

TRDA
Nov 05, 2026, 3:28 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $4.59
Real-time Price: $4.89 info
Change: +$0.300 (+7%) info
Market Cap: $190.4M info
TRDA
Oct 14, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $5.03
Real-time Price: $4.89 info
Change: -$0.140 (-3%) info
Market Cap: $190.4M info
TRDA
Aug 05, 2026, 7:11 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $7.25
Real-time Price: $4.89 info
Change: -$2.36 (-33%) info
Market Cap: $190.4M info
TRDA
Aug 05, 2026, 7:04 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.25
Real-time Price: $4.89 info
Change: -$2.36 (-33%) info
Market Cap: $190.4M info
TRDA
Jun 10, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.80
Real-time Price: $4.89 info
Change: -$0.910 (-16%) info
Market Cap: $190.4M info